- Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes
-
Jeon YK, Kim MR, Huh JE, Mok JY, Song SH, Kim SS, Kim BH, Lee SH, Kim YK, Kim IJ
- KMID: 1782115
- J Korean Med Sci.
- 2011 Feb;26(2):258-263.
- doi: 10.3346/jkms.2011.26.2.258
This study was done to evaluate clinical usefulness of cystatin C levels of serum and urine in predicting renal impairment in normoalbuminuric patients with type 2 diabetes and to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
-
Choe JY, Park SH, Kim SK
- KMID: 1713830
- J Korean Med Sci.
- 2010 Jan;25(1):42-48.
- doi: 10.3346/jkms.2010.25.1.42
Serum creatinine level is the most commonly used indices for assessment of glomerular filtration rate (GFR), even though these indices have been shown to have some limitations in clinical practice.... -
- CITED
-
- Close
- SHARE
-
- Close
- Urinary excretion of beta2-microglobulin as a prognostic marker in immunoglobulin A nephropathy
-
Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG
- KMID: 1792059
- Korean J Intern Med.
- 2014 May;29(3):334-340.
- doi: 10.3904/kjim.2014.29.3.334
BACKGROUND/AIMS: beta2-microglobulin (beta2-MG) is freely filtered at the glomerulus and subsequently reabsorbed and catabolized by proximal renal tubular cells. Urinary beta2-MG is an early and sensitive biomarker of acute kidney... -
- CITED
-
- Close
- SHARE
-
- Close
- Short-Term Efficacy of Enzyme Replacement Therapy in Korean Patients with Fabry Disease
-
Choi JH, Cho YM, Suh KS, Yoon HR, Kim GH, Kim SS, Ko JM, Lee JH, Park YS, Yoo HW
- KMID: 1713456
- J Korean Med Sci.
- 2008 Apr;23(2):243-250.
- doi: 10.3346/jkms.2008.23.2.243
Fabrazyme has been widely used for treatment of Fabry disease since its approval by the U.S. Food and Drug Administration in 2003. This study was undertaken to assess the short-term... -
- CITED
-
- Close
- SHARE
-
- Close
- Serum Chemerin Levels Are Associated with Abdominal Visceral Fat in Type 2 Diabetes
-
Han J, Kim SH, Suh YJ, Lim HA, Shin H, Cho SG, Kim CW, Lee SY, Lee DH, Hong S, Kim YS, Nam MS
- KMID: 2373702
- J Korean Med Sci.
- 2016 Jun;31(6):924-931.
- doi: 10.3346/jkms.2016.31.6.924
Chemerin is a recently identified adipokine suggested to play a role in obesity and its metabolic complications. The relationship between visceral obesity and serum chemerin levels in type 2 diabetes... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Dipper Status and Left Ventricular Hypertrophy as Predictors of Incident Chronic Kidney Disease
-
An HR, Park S, Yoo TH, Kang SW, Ryu JH, Lee YK, Yu M, Ryu DR, Kim SJ, Kang DH, Choi KB
- KMID: 1779392
- J Korean Med Sci.
- 2011 Sep;26(9):1185-1190.
- doi: 10.3346/jkms.2011.26.9.1185
We have hypothesized that non-dipper status and left ventricular hypertrophy (LVH) are associated with the development of chronic kidney disease (CKD) in non-diabetic hypertensive patients. This study included 102 patients... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case Report of a Middle East Respiratory Syndrome Survivor with Kidney Biopsy Results
-
Cha RH, Yang SH, Moon KC, Joh JS, Lee JY, Shin HS, Kim DK, Kim YS
- KMID: 2363706
- J Korean Med Sci.
- 2016 Apr;31(4):635-640.
- doi: 10.3346/jkms.2016.31.4.635
A 68-year old man diagnosed with Middle East Respiratory Syndrome-Coronavirus (MERS-CoV) presented with multiple pneumonic infiltrations on his chest X-ray, and the patient was placed on a mechanical ventilator because... -
- CITED
-
- Close
- SHARE
-
- Close
